As we advance through 2024, significant updates in Human Immunodeficiency Virus (HIV) and Sexually Transmitted Infections (STI) prevention and treatment are emerging. How will these developments shape future strategies in HIV and STI management?

Recent years have witnessed a sea-change in how laboratory tests have been employed to diagnose, monitor, and manage viral infections.

Genomics is a powerful tool for conserving endangered species, informing researchers of taxonomy and population connectivity and helping to develop strategies for mitigating disease and the effects of climate change.

In this webinar, Dr. James Dunn will join us to discuss the process for the practical implementation of multiplex molecular assays for infectious diseases at different points of service.

Throughout the session, Dr. Dunn will also cover the role of diagnostic stewardship in ensuring patients receive testing with the appropriate diagnostic modality. There are many challenges and opportunities with the integration of molecular microbiology testing in different settings and with proper test selection and utilization, there can be significant benefits in patient outcomes.

In this webinar, Dr. James E. Crowe from Vanderbilt University Medical Center will discuss current approaches to screening for high potency, broad reactivity, synergistic combinations and reduced escapability.

In this webinar, our expert speaker will discuss the types of analytical testing that can be effectively employed in the early stages of therapeutic development and subsequently scaled to meet production challenges.